Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension

• Status: Recruiting
• Trial end date: 2022-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this research study is to assess the safety and feasibility of lowering intraocular pressure (IOP) using an experimental study drug, JV-GL1.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: JeniVision, Inc.
• Treatments: Latanoprost; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• bilateral open-angle glaucoma or ocular hypertension

Exclusion Criteria:

-